Zhao N, Khan R, Hung M, Zhang C, Wang S, Wang T
Sci Rep. 2024; 14(1):22122.
PMID: 39333688
PMC: 11437163.
DOI: 10.1038/s41598-024-72284-4.
Pratap U, Tidwell M, Balinda H, Clanton N, Yang X, Viswanadhapalli S
Mol Cancer Ther. 2023; 22(11):1248-1260.
PMID: 37493258
PMC: 10811744.
DOI: 10.1158/1535-7163.MCT-23-0031.
de Lucio Delgado A, Rubio J, Riano-Galan I, Perez Gordon J
Children (Basel). 2023; 10(1).
PMID: 36670665
PMC: 9856414.
DOI: 10.3390/children10010115.
Lee J, Troike K, Fodor R, Lathia J
Endocrinology. 2022; 163(3).
PMID: 35023543
PMC: 8807164.
DOI: 10.1210/endocr/bqac002.
Zhao N, Wang F, Ahmed S, Liu K, Cathcart S, DiMaio D
Front Oncol. 2021; 11:616625.
PMID: 34094902
PMC: 8175980.
DOI: 10.3389/fonc.2021.616625.
Impact of sex in the prevalence and progression of glioblastomas: the role of gonadal steroid hormones.
Bello-Alvarez C, Camacho-Arroyo I
Biol Sex Differ. 2021; 12(1):28.
PMID: 33752729
PMC: 7986260.
DOI: 10.1186/s13293-021-00372-5.
Estradiol Induces Epithelial to Mesenchymal Transition of Human Glioblastoma Cells.
Hernandez-Vega A, Del Moral-Morales A, Zamora-Sanchez C, Pina-Medina A, Gonzalez-Arenas A, Camacho-Arroyo I
Cells. 2020; 9(9).
PMID: 32825553
PMC: 7564468.
DOI: 10.3390/cells9091930.
Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity.
Altinoz M, Ucal Y, Yilmaz M, Kiris I, Ozisik O, Sezerman U
Cancer Med. 2020; 9(16):5767-5780.
PMID: 32590878
PMC: 7433824.
DOI: 10.1002/cam4.3223.
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
Zhou M, Sareddy G, Li M, Liu J, Luo Y, Pitta Venkata P
Sci Rep. 2019; 9(1):6124.
PMID: 30992459
PMC: 6467924.
DOI: 10.1038/s41598-019-42313-8.
Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz M, Ozpinar A, Elmaci I
Neurosurg Rev. 2018; 42(2):351-369.
PMID: 29453736
DOI: 10.1007/s10143-018-0953-1.
Update on the therapeutic significance of estrogen receptor beta in malignant gliomas.
Lan Y, Zou S, Wang X, Lou J, Xing J, Yu M
Oncotarget. 2017; 8(46):81686-81696.
PMID: 29113424
PMC: 5655319.
DOI: 10.18632/oncotarget.20970.
Expression of estrogen and progesterone receptors in astrocytomas: a literature review.
Tavares C, Gomes-Braga F, Costa-Silva D, Escorcio-Dourado C, Borges U, Conde-Junior A
Clinics (Sao Paulo). 2016; 71(8):481-6.
PMID: 27626480
PMC: 4975780.
DOI: 10.6061/clinics/2016(08)12.
Cancer therapy using natural ligands that target estrogen receptor beta.
Sareddy G, Vadlamudi R
Chin J Nat Med. 2015; 13(11):801-807.
PMID: 26614454
PMC: 4896163.
DOI: 10.1016/S1875-5364(15)30083-2.
Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model.
Paterni I, Bertini S, Granchi C, Tuccinardi T, Macchia M, Martinelli A
J Med Chem. 2015; 58(3):1184-94.
PMID: 25559213
PMC: 4610302.
DOI: 10.1021/jm501829f.
Evidence for involvement of steroid receptors and coactivators in neuroepithelial and meningothelial tumors.
Liu M, Zhang K, Zhao Y, Guo Q, Guo D, Zhang J
Tumour Biol. 2014; 36(5):3251-61.
PMID: 25534237
DOI: 10.1007/s13277-014-2954-1.
Androgen receptor signaling regulates growth of glioblastoma multiforme in men.
Yu X, Jiang Y, Wei W, Cong P, Ding Y, Xiang L
Tumour Biol. 2014; 36(2):967-72.
PMID: 25315188
DOI: 10.1007/s13277-014-2709-z.
Aromatase and estrogen receptor alpha mRNA expression as prognostic biomarkers in patients with astrocytomas.
Duenas Jimenez J, Candanedo Arellano A, Santerre A, Orozco Suarez S, Sandoval Sanchez H, Feria Romero I
J Neurooncol. 2014; 119(2):275-84.
PMID: 25005528
DOI: 10.1007/s11060-014-1509-z.
Progesterone induces the growth and infiltration of human astrocytoma cells implanted in the cerebral cortex of the rat.
German-Castelan L, Manjarrez-Marmolejo J, Gonzalez-Arenas A, Gonzalez-Moran M, Camacho-Arroyo I
Biomed Res Int. 2014; 2014:393174.
PMID: 24982875
PMC: 4054953.
DOI: 10.1155/2014/393174.
A pooled multisite analysis of the effects of female reproductive hormones on glioma risk.
Krishnamachari B, Ilyasova D, Scheurer M, Bondy M, Wrensch M, Davis F
Cancer Causes Control. 2014; 25(8):1007-13.
PMID: 24890803
PMC: 4288736.
DOI: 10.1007/s10552-014-0400-8.
Tumor progression and transformation of low-grade glial tumors associated with pregnancy.
Daras M, Cone C, Peters K
J Neurooncol. 2013; 116(1):113-7.
PMID: 24078174
DOI: 10.1007/s11060-013-1261-9.